Boaz Weinstein’s ZyVersa Therapeutics, Inc. Warrants ZVSAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-86,247
Closed -$10K 1070
2022
Q3
$10K Hold
86,247
﹤0.01% 1019
2022
Q2
$8K Hold
86,247
﹤0.01% 1063
2022
Q1
$15K Buy
+86,247
New +$17.5K ﹤0.01% 934

Boaz Weinstein's ZVSAW Position: Q4 2022 in Review

Boaz Weinstein sold out of ZyVersa Therapeutics, Inc. Warrants (ZVSAW) in Q4 2022, closing a stake of 86,247 shares — an estimated $10K sold.

Boaz Weinstein first reported a position in ZVSAW in Q1 2022 and held it in 3 quarters. The position peaked at $15K in Q1 2022. 1 fund tracked by Wall St. Rank holds ZVSAW as of Q4 2022.

  • Boaz Weinstein reported no remaining ZyVersa Therapeutics, Inc. Warrants position as of Q4 2022 after selling out during the quarter.
  • Boaz Weinstein sold 86,247 ZyVersa Therapeutics, Inc. Warrants shares in Q4 2022, an estimated $10K.
  • Boaz Weinstein first reported a position in ZyVersa Therapeutics, Inc. Warrants in Q1 2022 and held it in 3 quarters.
  • Boaz Weinstein's ZyVersa Therapeutics, Inc. Warrants position peaked at $15K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held ZyVersa Therapeutics, Inc. Warrants as of Q4 2022.

Based on Saba Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.